Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways
- PMID: 22683312
- PMCID: PMC3409440
- DOI: 10.1016/j.ajpath.2012.04.024
Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways
Abstract
Pancreatic disease has onset in utero in humans with cystic fibrosis (CF), and progresses over time to complete destruction of the organ. The exact mechanisms leading to pancreatic damage in CF are incompletely understood. Inflammatory cells are present in the pancreas of newborn pigs with CF (CF pigs) and humans, which suggests that inflammation may have a role in the destructive process. We wondered whether tissue inflammation and genes associated with inflammatory pathways were increased in the pancreas of fetal CF pigs [83 to 90 days gestation (normal pig gestation is ~114 days)] and newborn pigs. Compared with fetal pigs without CF (non-CF pigs), in fetal CF pigs, the pancreas exhibited patchy inflammation and acinar atrophy, with progression in distribution and severity in neonatal CF pigs. Large-scale transcript profiling revealed that the pancreas in fetal and newborn CF pigs exhibited significantly increased expression of proinflammatory, complement cascade, and profibrotic genes when compared with fetal and newborn non-CF pigs. Acinar cells exhibited increased apoptosis in the pancreas of fetal and newborn CF pigs. α-Smooth muscle actin and transforming growth factor β1 were increased in both fetal and newborn CF pig pancreas, suggesting activation of profibrotic pathways. Cell proliferation and mucous cell metaplasia were detected in newborn, but not fetal, CF pigs, indicating that they were not an initiator of pathogenesis but a response. Proinflammatory, complement cascade, proapoptotic, and profibrotic pathways are activated in CF pig pancreas, and likely contribute to the destructive process.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures






Similar articles
-
An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.Pancreatology. 2011;11(5):506-15. doi: 10.1159/000332582. Epub 2011 Nov 1. Pancreatology. 2011. PMID: 22057257 Free PMC article.
-
Stellate cells are in utero markers of pancreatic disease in cystic fibrosis.Mol Med. 2024 Aug 7;30(1):115. doi: 10.1186/s10020-024-00871-2. Mol Med. 2024. PMID: 39112965 Free PMC article.
-
Newborn Cystic Fibrosis Pigs Have a Blunted Early Response to an Inflammatory Stimulus.Am J Respir Crit Care Med. 2016 Oct 1;194(7):845-854. doi: 10.1164/rccm.201510-2112OC. Am J Respir Crit Care Med. 2016. PMID: 27027566 Free PMC article.
-
Lessons learned from the cystic fibrosis pig.Theriogenology. 2016 Jul 1;86(1):427-32. doi: 10.1016/j.theriogenology.2016.04.057. Epub 2016 Apr 21. Theriogenology. 2016. PMID: 27142487 Free PMC article. Review.
-
Exocrine pancreatic function in cystic fibrosis.Eur J Gastroenterol Hepatol. 1996 Aug;8(8):755-9. Eur J Gastroenterol Hepatol. 1996. PMID: 8864671 Review.
Cited by
-
Amelioration of airway and GI disease in G551D-CF ferrets by AAV1 and AAV6.Gene Ther. 2024 Sep;31(9-10):499-510. doi: 10.1038/s41434-024-00469-7. Epub 2024 Jul 28. Gene Ther. 2024. PMID: 39069560
-
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.Am J Respir Crit Care Med. 2023 Jul 1;208(1):59-67. doi: 10.1164/rccm.202301-0084OC. Am J Respir Crit Care Med. 2023. PMID: 36921081 Free PMC article.
-
Deconstructing the principles of ductal network formation in the pancreas.PLoS Biol. 2018 Jul 26;16(7):e2002842. doi: 10.1371/journal.pbio.2002842. eCollection 2018 Jul. PLoS Biol. 2018. PMID: 30048442 Free PMC article.
-
A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR.Am J Respir Crit Care Med. 2022 Nov 15;206(10):1239-1247. doi: 10.1164/rccm.202204-0734OC. Am J Respir Crit Care Med. 2022. PMID: 35771568 Free PMC article. Clinical Trial.
-
The porcine innate immune system: an update.Dev Comp Immunol. 2014 Aug;45(2):321-43. doi: 10.1016/j.dci.2014.03.022. Epub 2014 Apr 4. Dev Comp Immunol. 2014. PMID: 24709051 Free PMC article. Review.
References
-
- Welsh M.J., Ramsey B.W., Accurso F.J., Cutting G.R. Cystic fibrosis. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., editors. The Metabolic and Molecular Bases of Inherited Disease. ed 8. McGraw-Hill; New York: 2001. pp. 5121–5188.
-
- Borowitz D., Durie P.R., Clarke L.L., Werlin S.L., Taylor C.J., Semler J., De Lisle R.C., Lewindon P., Lichtman S.M., Sinaasappel M., Baker R.D., Baker S.S., Verkade H.J., Lowe M.E., Stallings V.A., Janghorbani M., Butler R., Heubi J. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2005;41:273–285. - PubMed
-
- Ooi C.Y., Dorfman R., Cipolli M., Gonska T., Castellani C., Keenan K., Freedman S.D., Zielenski J., Berthiaume Y., Corey M., Schibli S., Tullis E., Durie P.R. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140:153–161. - PubMed
-
- Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J. 2007;29:522–526. - PubMed
-
- Kopelman H., Durie P., Gaskin K., Weizman Z., Forstner G. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med. 1985;312:329–334. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical